As of 2025-07-04, the Fair Value of ACRO Biomedical Co Ltd (ACBM) is -1.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of ACRO Biomedical Co Ltd is -180,217.86%.
With the market price of 0.00 USD and our fair value calculation, ACRO Biomedical Co Ltd (ACBM) is not a good investment. Investing in ACBM stocks now will result in a potential loss of 180,217.86%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-09-30 | 2019-09-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | 0.42 | -0.37 | -0.12 | -7.70 | -15.87 | -6.02 |
| YoY growth | -% | -188.10% | 67.57% | -6,316.67% | -106.10% | -1,635.82% |
| Market Cap (mil) | 0.04 |
| P/E | |
| Forward P/E |
| EPS | -0.25 |
| Avg earnings growth rate | -1,635.82% |
| TTM earnings | -15.14 |